These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
739 related items for PubMed ID: 20406085
1. Tuberculosis in Europe: a problem of drug resistance or much more? Carvalho AC, Migliori GB, Cirillo DM. Expert Rev Respir Med; 2010 Apr; 4(2):189-200. PubMed ID: 20406085 [Abstract] [Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H, Namba K. Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [Abstract] [Full Text] [Related]
3. Extensively drug-resistant tuberculosis in california, 1993-2006. Banerjee R, Allen J, Westenhouse J, Oh P, Elms W, Desmond E, Nitta A, Royce S, Flood J. Clin Infect Dis; 2008 Aug 15; 47(4):450-7. PubMed ID: 18616396 [Abstract] [Full Text] [Related]
7. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment. Ormerod LP. Br Med Bull; 2005 Jun 15; 73-74():17-24. PubMed ID: 15956357 [Abstract] [Full Text] [Related]
8. Low levels of drug resistance amidst rapidly increasing tuberculosis and human immunodeficiency virus co-epidemics in Botswana. Kenyon TA, Mwasekaga MJ, Huebner R, Rumisha D, Binkin N, Maganu E. Int J Tuberc Lung Dis; 1999 Jan 15; 3(1):4-11. PubMed ID: 10094163 [Abstract] [Full Text] [Related]
9. Extensively drug-resistant tuberculosis: new strains, new challenges. Banerjee R, Schecter GF, Flood J, Porco TC. Expert Rev Anti Infect Ther; 2008 Oct 15; 6(5):713-24. PubMed ID: 18847407 [Abstract] [Full Text] [Related]
10. [Tuberculosis in Poland, Europe, and world. Part II--mortality, drug resistance and HIV infection]. Zielonka TM. Pol Merkur Lekarski; 2006 Sep 15; 21(123):253-61. PubMed ID: 17163187 [Abstract] [Full Text] [Related]
11. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. Fears R, Kaufmann S, Ter Meulen V, Zumla A, EASAC Working Group. Tuberculosis (Edinb); 2010 May 15; 90(3):182-7. PubMed ID: 20382566 [Abstract] [Full Text] [Related]
12. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions. Prasad R. Indian J Tuberc; 2010 Oct 15; 57(4):180-91. PubMed ID: 21141336 [Abstract] [Full Text] [Related]
13. [Drug resistant tuberculosis]. Zwolska Z, Augustynowicz-Kopeć E. Pol Merkur Lekarski; 2011 May 15; 30(179):362-6. PubMed ID: 21675144 [Abstract] [Full Text] [Related]
14. Multidrug-resistant and extensively drug-resistant tuberculosis in the West. Europe and United States: epidemiology, surveillance, and control. Migliori GB, D'Arcy Richardson M, Sotgiu G, Lange C. Clin Chest Med; 2009 Dec 15; 30(4):637-65, vii. PubMed ID: 19925959 [Abstract] [Full Text] [Related]
15. HIV infection and multidrug-resistant tuberculosis: the perfect storm. Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, Castro KG, Weyer K. J Infect Dis; 2007 Aug 15; 196 Suppl 1():S86-107. PubMed ID: 17624830 [Abstract] [Full Text] [Related]
19. [Epidemiology of drug-resistant tuberculosis: world--Europe--Poland]. Jagielski T, Augustynowicz-Kopeć E, Zwolska Z. Wiad Lek; 2010 Apr 15; 63(4):345-57. PubMed ID: 21612049 [Abstract] [Full Text] [Related]
20. [Multidrug resistant tuberculosis in Romania in the last years (2004-2007)--an extremely important social phenomenon]. Marica C, Didilescu C, Chiotan D, Galie N, Tănăsescu M, Popescu-Hagen M, Popa M. Pneumologia; 2008 Apr 15; 57(4):195-200. PubMed ID: 19186681 [Abstract] [Full Text] [Related] Page: [Next] [New Search]